By: PCaSO DPO

10 AprHove PSA Testing event a success


PCaSO’s PSA event at Hove on 1st April saw 273 men attend for the blood test. After processing of the blood…

Read More

10 AprNew targeted treatment approved.


Olaparib is a drug with the potential to extend the lives of hundreds of prostate cancer patients, specifically those men with…

Read More

10 AprWorking to block metastatic spread


Prostate Cancer Research are funding a project to help identify drugs that could block prostate cancer cells from spreading in the…

Read More

10 AprNew blood test could help catch prostate cancer early


Swansea University have received a grant of £400,000 to research a potential new blood test to identify very specific sugars in…

Read More

05 AprUpcoming PCaSO meeting 16 June 2022


If you live in the Worthing to Littlehampton area why not come along to our next branch meeting, a talk by…

Read More

15 FebNew diagnostic blood test being developed


Researchers from Oxford BioDynamics, Imperial College and the University of East Anglia have developed a new blood test that is said…

Read More

15 FebFamily history can lift chance of PCa survival


The Institute of Cancer Research and Royal Marsden hospital analysed data from 16,000 men and established that prostate cancer patients who…

Read More

15 FebPCUK’s “March the Month” event


Prostate Cancer UK are holding a month-long awareness/fundraising fitness event in March. The challenge is to walk 11,000 steps each day…

Read More

02 NovPCaSO donates £2,000 to the Mary How Trust


The Mary How Trust is a registered charity based in Pulborough, West Sussex, dedicated to providing an important screening service for…

Read More

02 NovZoom event **14 November** on High Intensity Focussed Ultrasound


We have arranged an excellent Zoom presentation on Monday 14th November at 19.00. Professor Mark Emberton OBE, Dean of UCL’s Faculty of…

Read More